Assessing Iran's Nuclear Goals

{
  "authors": [
    "Karim Sadjadpour"
  ],
  "type": "legacyinthemedia",
  "centerAffiliationAll": "dc",
  "centers": [
    "Carnegie Endowment for International Peace"
  ],
  "collections": [],
  "englishNewsletterAll": "ctw",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie Endowment for International Peace",
  "programAffiliation": "NPP",
  "programs": [
    "Nuclear Policy",
    "Middle East"
  ],
  "projects": [],
  "regions": [
    "Middle East",
    "Iran"
  ],
  "topics": [
    "Nuclear Policy"
  ]
}

In The Media

Assessing Iran's Nuclear Goals

By Karim Sadjadpour

Published on Jan 2, 2008

Source: NPR's All Things Considered

Over the past year, tensions between Iran and the United States have risen to unprecedented levels. At the same time, Iranian President Mahmoud Ahmadinejad faces more criticism internally than at any time since he took office more than two years ago. Carnegie's Karim Sadjadpour speaks with Mike Shuster with a year-end look at the ongoing controversy and diplomacy surrounding Iran's nuclear program.

Click here to listen to the radio broadcast.

About the Author

Karim Sadjadpour

Senior Fellow, Middle East Program

Karim Sadjadpour is a senior fellow at the Carnegie Endowment for International Peace, where he focuses on Iran and U.S. foreign policy toward the Middle East.

Recent Work

Q&A
What’s Keeping the Iranian Regime in Power—for Now
- Aaron David Miller, Karim Sadjadpour, Robin Wright
Q&A
How Washington and Tehran Are Assessing Their Next Steps
- Aaron David Miller, David Petraeus, Karim Sadjadpour

Nuclear Policy Middle East Iran

Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie India

Article
Risk and Retaliation: Israel, Iran, and the Evolving Situation in West Asia
An Israeli response to Iran’s October 1 attack is imminent. The key question is of its intensity and potential fallout, both within Iran, in terms of nuclear security policy changes, and across the broader region. The coming days are likely to reshape West Asia irreversibly.
Gaddam Dharmendra
Commentary
How WHO’s “One Health” Program Can Help India Tackle Monkeypox
With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.
Shruti Sharma
Paper
Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India
In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.
Shruti Sharma
Commentary
Combating Vaccine Hesitancy in India
Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.
Shruti Sharma
Commentary
How Should Countries Study Viruses Safely?
The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?
Shruti Sharma

More Work from Carnegie India

Article

Risk and Retaliation: Israel, Iran, and the Evolving Situation in West Asia

An Israeli response to Iran’s October 1 attack is imminent. The key question is of its intensity and potential fallout, both within Iran, in terms of nuclear security policy changes, and across the broader region. The coming days are likely to reshape West Asia irreversibly.

Gaddam Dharmendra

Commentary

How WHO’s “One Health” Program Can Help India Tackle Monkeypox

With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.

Shruti Sharma

Paper

Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India

In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.

Shruti Sharma

Commentary

Combating Vaccine Hesitancy in India

Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.

Shruti Sharma

Commentary

How Should Countries Study Viruses Safely?

The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?

Shruti Sharma